Intrinsiqs

Is LB Pharmaceuticals Inc Common Stock overvalued?

LB Pharmaceuticals Inc Common Stock (LBRX) — key valuation metrics and fundamentals.

No verdict
Price
$47.77
Fair value
Current P/E
Normal P/E
Market cap
$1.37B
Dividend yield
0.0%
Return on equity
-17.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares LBRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.